SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)
$CCRN
Professional Services
Consumer Discretionary
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/19/2026 | $15.00 | Neutral → Outperform | Wedbush |
| 3/5/2026 | $14.00 | Hold → Buy | The Benchmark Company |
| 2/3/2026 | $11.00 | Neutral | Wedbush |
| 12/4/2025 | $11.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
| 12/10/2024 | Outperform → Mkt Perform | Barrington Research | |
| 12/6/2023 | Mkt Perform | JMP Securities | |
| 11/3/2023 | $32.00 → $21.00 | Buy → Hold | Jefferies |
| 6/26/2023 | Outperform | William Blair |
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
Cross Country Healthcare, Inc. (NASDAQ:CCRN), a technology-driven healthcare workforce solutions company delivering an AI-powered digital platform and advisory services backed by nearly 40 years of healthcare labor expertise, today announced a new community partnership with Open Hearts for Orphans (OHFO), a South Florida nonprofit dedicated to providing hope, healing, and family for orphaned and vulnerable children. This partnership brings together two mission-driven organizations committed to strengthening families, supporting communities, and improving outcomes for vulnerable children and the caregivers who support them. Through this collaboration, Cross Country will support OHFO thro
Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761 (24 ) % (5 ) % $ 1,054,293 (22 ) % Gross profit margin* 20.3 % 30
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Truist Securities Virtual Human Capital Conference taking place March 12-13, 2026, with one-on-one investor meetings on Thursday, March 12. The Oppenheimer 36th Annual Healthcare MedTech & Services Conference taking place March 16-19, 2026, with one-on-one investor meetings on Tuesday, March 17. In attendance and participating in one-on-ones at both conferences will be William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice President, Investor Relations. No formal presentation will be made at either confe
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
10-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
3 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
Wedbush upgraded Cross Country from Neutral to Outperform and set a new price target of $15.00
The Benchmark Company upgraded Cross Country from Hold to Buy and set a new price target of $14.00
Wedbush initiated coverage of Cross Country with a rating of Neutral and set a new price target of $11.00
Co-Founder and Chairman, Kevin C. Clark, Returns as Chief Executive Officer Cross Country Healthcare, Inc. (the "Company" and "Cross Country") (NASDAQ:CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the "Board"), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Company's President and Chief Executive Officer. Mr. Clark will continue to serve as the Chairman of the Board. "The Board members are thrilled to have Kevin return
Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761 (24 ) % (5 ) % $ 1,054,293 (22 ) % Gross profit margin* 20.3 % 30
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026 at 5:00 P.M. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, March 4, 2026. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 800-369-2163 from anywhere in the U.S. or by dialing 773-756-4715 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from March 4th through March 18th on the Company's website and a replay of
Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information: Variance Variance Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052 (21 )% (9 )% Gross profit margin* 20.4 % — bps — bps Net loss attributable to common stockholders $ (4,774 ) (287 )%
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)